UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000035724
Receipt No. R000040677
Scientific Title Prospective study of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting using novel metal stent
Date of disclosure of the study information 2019/01/31
Last modified on 2019/08/02 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Prospective study of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting using novel metal stent
Acronym Prospective study of endoscopic ultrasound-guided hepaticogastrostomy with antegrade stenting using novel stent
Scientific Title Prospective study of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting using novel metal stent
Scientific Title:Acronym Prospective study of endoscopic ultrasound-guided hepaticogastrostomy with antegrade stenting using novel stent
Region
Japan

Condition
Condition Obstructive Jaundice
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the EUS-HGAS procedure success rate for unresectable malignant biliary obstructive cases using novel metal stent
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes EUS-HGAS procedure success rate
Key secondary outcomes Type, frequency of adverse events.
3 months after EUS - HGAS stent patency.
Clinical efficacy rate.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 EUS-HGS with EUS-AS using novet metal stent(Zilver type 2)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria nonresectable advanced malignant tumor case
Cases requiring biliary duct drainage due to malignant bile duct obstruction
Difficult cases of biliary drainage via Vater papilla approach
Cases in which survival is expected for more than 3 months
Key exclusion criteria Difficult cases of endoscopic approach
Perfomance status 4 case
Cases with serious complications in other organs
Informed consent case not available
Target sample size 25

Research contact person
Name of lead principal investigator
1st name Kazuhide
Middle name
Last name Higuchi
Organization Osaka Medical College Hospital
Division name Gastrointestinal Division
Zip code 569-8686
Address 2-7 Daigakumachi, Takatsuki, Osaka
TEL +81726831221
Email higuchi@osaka-med.ac.jp

Public contact
Name of contact person
1st name Saori
Middle name
Last name Ueno
Organization Osaka Medical College Hospital
Division name Gastrointestinal Division
Zip code 569-8686
Address 2-7 Daigakumachi, Takatsuki, Osaka
TEL +81726831221
Homepage URL
Email onchannopasocon@yahoo.co.jp

Sponsor
Institute Osaka Medical College
Institute
Department

Funding Source
Organization Osaka Medical College
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Osaka Medical College
Address 2-7 Daigakumachi, Takatsuki, Osaka
Tel 0726-83-1221
Email rinri@osaka-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大阪医科大学付属病院(大阪府)

Other administrative information
Date of disclosure of the study information
2019 Year 01 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2018 Year 11 Month 28 Day
Date of IRB
Anticipated trial start date
2019 Year 01 Month 09 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 01 Month 30 Day
Last modified on
2019 Year 08 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040677